Dec 26, 2023 | Alternative Reimbursement Strategies, Benefits preservation, Client Feedback, Client Surveys, Fair Market Pricing, ISO, Kurt Harden, MedBen Connect, MedBen Rx, President's Note
On behalf of the MedBen team, I wish you a happy and prosperous new year and thank you for your continued trust in MedBen. In 2023, we celebrated our 85th Anniversary. Those years have been marked by a variety of challenges and successes but I am particularly...
Dec 22, 2023 | Acquisition Cost Index (ACI) pricing, Cost Plus Pricing, Cost Savings, Drug costs, MedBen Rx, Pharmacy, Prescription, Rx Costs, Savings, Spread Pricing
Spread pricing is the difference between what pharmacy benefit managers (PBMs) charge health plans for drugs and what the pharmacy actually pays for them. Often, this “spread” can be substantial, as PBMs profit greatly from their lack of transparency… so it’s not...
Oct 30, 2023 | Appropriateness Solutions, Comparative Effectiveness, Drug costs, MedBen Rx, Pharmacy, Prescription, Research
MedBen Rx’s expanded pharmacy solutions offer a variety of ways to reduce your prescription drug spend… including appropriateness solutions that use clinical-based research to recommend the most effective drugs to your plan members. Comparative...
Oct 16, 2023 | Cost Savings, MedBen Rx, Pharmacy, Prescription, Rx Costs, Savings
From a new report published by the U.S. Department of Health & Human Services: “Over the period from January 2022 to January 2023, more than 4,200 drug products had price increases, of which 46 percent were larger than the rate of inflation. The average drug...
Oct 3, 2023 | MedBen Rx, Pharmacy Benefits Manager (PBM), Rebates, White paper
In their continuing quest for bigger profits, major pharmacy benefit managers (PBMs) have adapted a new tactic: clever wordplay. What was once known as a “rebate” – a partial refund of the drug payment back to the plan – now goes by a variety of other...
Sep 29, 2023 | Announcements, Biosimilars, Humira, MedBen Rx, News, Perigon Pharmacy 360, Ventegra
Here’s some cost-saving news for MedBen Rx clients. On July 1, 2023, biosimilar products were released for the popular and expensive anti-inflammatory therapy, Humira. A 30-day supply of Humira, which is used to treat a variety of conditions from Crohn’s to...
